Skip to main content
Veterinary Medicines

Norocarp,100 mg, tablet

Authorised
  • Carprofen

Product identification

Medicine name:
Norocarp,100 mg, tablet
Norocarp 100 mg Tablett
Active substance:
  • Carprofen
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Carprofen
    100.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AE91
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Available in:
  • Sweden
Package description:
  • Blister, 10 tablets
  • Blister, 70 tablets
  • Blister, 100 tablets
  • Blister, 60 tablets
  • Blister, 140 tablets
  • Blister, 50 tablets
  • Blister, 180 tablets
  • Blister, 30 tablets
  • Blister, 200 tablets
  • Blister, 20 tablets
  • Blister, 250 tablets
  • Blister, 300 tablets
  • Blister, 280 tablets
  • Blister, 500 tablets
  • Blister, 1000 tablets
  • Jar, 30 tablets
  • Jar, 100 tablets
  • Jar, 14 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Manufacturing Limited
  • Norbrook Laboratories Limited
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 26839
Date of authorisation status change:
Reference member state:
  • Sweden
Procedure number:
  • SE/V/0122/001
Concerned member states:
  • Austria
  • Denmark
  • Finland
  • Germany
  • Portugal

Documents

Package Leaflet

English (PDF)
Published on: 26/04/2022
Download
Swedish (PDF)
Published on: 26/04/2022

Summary of Product Characteristics

English (PDF)
Published on: 26/04/2022
Download
Swedish (PDF)
Published on: 26/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."